|
 |
NavelbineThis page contains recent news articles, when available, and an overview of Navelbine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.The San Diego company said the drug, ANX-530, is a new formulation of the chemotherapy drug Navelbine. The company said its studies aimed to show the drug ... San Diego Union Tribune Adventrx Sends Drug to FDA, Sells Preferred Stock - Jan 4, 2010 Studies have shown the drug to be bioequivalent to currently marketed Navelbine but without the vein irritation associated with intravenous delivery of the ... San Diego Business Journal Adventrx Pharmaceuticals Inc. (AMEX: ANX) still running strong. Gains nearly ... - Dec 28, 2009 Navelbine, a branded formulation of vinorelbine, is approved in the US to treat advanced non-small cell lung cancer. The ANX-530 formulation emulsifies ... Small Cap Network Adventrx Inching Closer To NDA Filing Of Emulsion Formulation Of Chemotherapy Drug - Dec 20, 2009 Navelbine, a branded formulation of vinorelbine, is approved in the US to treat advanced non-small cell lung cancer as a single agent or in combination with ... RTT News ADENTRX set to move in on GlaxoSmithKline's lucrative oncology drug - Jan 4, 2010 The problem with the current form of GlaxoSmithKline's (NYSE:GSK) Navelbine is that the injection site reaction is 30%. Understand that Oncology products ... FOXBusiness Neratinib Shows Promise in Treatment of HER2-positive Breast Cancer - Dec 18, 2009 At SABCS 2009 the results of an ongoing Phase I/II clinical trial of neratinib in combination with Navelbine® (vinorelbine) in women with HER2-positive ... Cancer Consultants Ichan's Adventrx Pharmaceuticals Ready To Run - Dec 23, 2009 Navelbine, is approved by the FDA to treat advanced non-small cell lung cancer, and approved in Europe to treat non-small cell lung cancer and advanced or ... FOXBusiness Gold & Dollar Redux, Looks at TRLG, MNKD, BBI, MNTA, ANX, & NEWP - Dec 24, 2009 The new drug turns the chemotherapy drug vinorelbine tartrate - or Navelbine - into an emulsion intended to treat non-small cell lung cancer. ... Small Cap Network Kathy Kemp: My good doctor and me - Dec 20, 2009 I've had, I guess, eight different chemos, the latest Navelbine. I spent six months on the chemo Abraxane before taking a break after Thanksgiving. ... The Birmingham News - al.com (blog) Prise de tête - Dec 26, 2009 Mais est-ce que retarder ainsi davantage l'ajout de Navelbine va m'être profitable ? Pas sûr. D'autant que je n'ai plus aucune chimiothérapie (Herceptin ... Libération La pervenche de Madagascar contre le cancer de la vessie - Dec 10, 2009 La plante est déjà à l'origine d'un autre médicament anti-cancéreux, la Navelbine. La nouvelle molécule a été synthétisée à partir de la Navelbine, ... Romandie.com Le ciboulot bombardé - Dec 22, 2009 Il m' annoncé que j'allais avoir de la Navelbine en chimiothérapie. La décision a été prise à l'issue d'un staff pluridisciplinaire. Ça sera en janvier, ... Libération Rues de Veyrinas, Auriol et de la Vierge rouge - Dec 26, 2009 Ce sont Pierre Potier, «certainementle plus grand phytochimiste français à l'origine des deux principaux médicaments contre le cancer, la Navelbine et le ... LaDépêche.fr ADVENTRX Pharmaceuticals Reports Third Quarter Financial Results - Nov 10, 2009 ...including bias that increased the reporting of adverse events associated with Navelbine and/or that decreased the reporting of adverse events associated ... CNNMoney.com (press release) Life is precious, no matter what; but it could be worse - Nov 6, 2009 From being fed intravenously with Herceptin and Navelbine plus the old treatments of mastectomy, chemotherapy and radiation, also known as slash, ... Daily Nation New Oral Agent, Tasquinimod, May Have Activity in Prostate Cancer - Oct 26, 2009 Chemotherapy agents for patients with HRPC include: Taxotere® (docetaxel), Emcyt® (estramustine), Novantrone® (mitoxantrone), ixabepilone, Navelbine® ... Cancer Consultants ADVENTRX Provides Business Update Following Recent Financing Activity - Oct 20, 2009 ...which activities may increase the cost and timeline to NDA submission or approval; the risk the FDA will determine that ANX-530 and Navelbine® are not ... Reuters ADVENTRX Announces ANX-530 Safety Data and Provides NDA … - Jan 14, 2008 ANX-530 demonstrated a statistically significant reduction in injection site reactions when compared to Navelbine(R) (p<0.05). The incidence of injection ... Free with registration - PR Newswire - AccessMyLibrary.com … -530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a ... - Apr 15, 2008 ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research ESMO: Cisplatin-Navelbine Duo Shows Survival Edge in NSCLC - Oct 6, 2006 By Rabiya Tuma, Ph.D., Contributing Writer, MedPage Today. ISTANBUL, Turkey, Oct. 6 -- Cisplatin-Navelbine (vinorelbine) reduces the risk of death in fully ... MedPage Today ADVENTRX Announces ANX-530 Safety Data From Registrational … - May 16, 2008 In the first week, patients were dosed with either ANX-530 or Navelbine, ... Navelbine, a branded formulation of vinorelbine, is approved in the US to treat ... Lifescience-online Platinol and Navelbine helps cancer patients - Oct 10, 2006 Lung cancer remains the leading cause of cancer-related death in the United States. Non-small cell lung cancer (NSCLC) comprises the majority of lung ... TopCancerNews.com Navelbine receives additional indication for inoperable/recurrent... - Jun 13, 2005 On 31 May 2005, Japanese approval was granted to Kyowa Hakko Kogyo for Navelbine Inj (vinorelbine) to be used in the treatment of inoperable or recurrent ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Gene Profiling Predicts Resistance To Breast Cancer Drug Herceptin - Feb 21, 2007 ..."We were motivated to use Navelbine because we found it has few side effects when used to treat metastatic breast cancer," said Harris, who conducted much ... sciencedaily.com Adventrx Pharmaceuticals Receives FDA Approval For Cancer Treatment … - Dec 26, 2006 Adventrx will begin patient recruitment for a new study to establish the bioequivalence of ANX_530 and Navelbine, an anti-cancer agent approved for use in ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com ANX-530 causes fewer injection site reactions than Navelbine in trial. - Jan 21, 2008 San Diego, USA-based Adventrx Pharmaceuticals, an R&D focused biopharmaceutical firm, says that ANX-530 (vinorelbine emulsion), its lung cancer treatment, ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Adventrx to initiate trials of potential cancer drug - Oct 2, 2007 ...trials to show that its ANX-530 drug works in the same manner as an existing anti-cancer agent, Navelbine, approved to fight non-small cell lung cancer. ... newratings.com Navelbine® and Platinol® found helpful for mesothelioma - Jul 18, 2008 Patients with newly diagnosed non-resectable pleural mesothelioma may benefit from the combination of Navelbine® (vinorelbine) and Platinol® (cisplatin), ... Mesothelioma News REGULATORY NEWS IN BRIEF - Jun 13, 2005 Kyowa Hakko Kogyo announced on June 3 that its Navelbine Inj. (vinorelbine) ... Navelbine Inj. is a plant-derived vinca alkaloid anti-malignant tumor agent ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Tarceva in the Elderly is NOT "Without Major Toxicity" - Mar 26, 2007 ...that are experienced with Tarceva can have a more profound impact on QOL than single agent systemic chemotherapy (eg weekly Taxane or Navelbine). ... Gerson Lehrman Group Navelbine causing intestinal neuropathy? - Aug 1, 2008 Question from Joette: I go in for my third Navelbine treatment on Thursday. My stomach pain has gotten out of control. What is intestinal neuropathy? ... Breastcancer.org Early studies show positive results for Afinitor - Dec 15, 2008 In the study, Afinitor in combination with Herceptin and Navelbine halted tumor growth in 62% of patients. "Data presented at this meeting affirm the ... Pharmacy Europe Switzerland pharma: Afinitor may overcome Herceptin resistance - Dec 17, 2008 ...patients with HER2-positive metastatic breast cancer. In the study, Afinitor plus Herceptin and Navelbine halted tumor growth in 62% of patients. $34.00 - EIU Country Analysis - Alacra Store Adjuvant Chemotherapy May Improve NSCLC Survival - Aug 18, 2006 18 -- Adjuvant Navelbine (vinorelbine)-Platinol (cisplatin) improved overall survival ... Ninety percent of the chemotherapy patients received Navelbine and ... MedPage Today å?£æœ?å¼?乳癌化療用藥末期乳癌患者新處方 - Aug 28, 2008 ...時而至今，許多å?£æœ?å¼?藥物的療效已與é‡?劑的療效相å?Œï¼Œã€Œæº«è«¾å¹³Â®NAVELBINE®ã€?就是最 明顯的例å?之一。 乳癌治療æˆ?功率的關é?µåœ¨æ–¼èƒ½å?¦åœ¨ç™¼ç?¾çš„第一時間接å?—æ£ç¢ºé†«ç™‚，莫 ... è‡ªç«‹æ™šå ± Kyowa Hakko Kogyo Obtains Additional Approval for Its Antitumor Agents - Jun 4, 2005 Navelbine Injection 40 and Navelbine Injection 10 are now available for the treatment of inoperable or recurrent breast cancer. ... Medical News Today - Medical News Today (press release) New Breast Cancer Drug Combination Proves More Effective - Mar 16, 2007 One group of women was treated with Gemzar (gemcitabine) and Navelbine (vinorelbine), the other group was treated with Navelbine alone. ... TopCancerNews.com ADVENTRX Cleared To Initiate Vinorelbine Emulsion Bioequivalence … - Dec 29, 2006 The study is a multicenter, open-label, randomized crossover comparison of ANX-530 and the approved reference product Navelbine(R) (vinorelbine tartrate) in ... Medical News Today - Medical News Today (press release) Loislaw Federal District Court Opinions - REID v. SMITHKLINE … - Apr 11, 2005 In November 2002 GSK conducted a two and a half week training program on Hycamtin and Navelbine for transfers to the Oncology division. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw ASCO: Any Age Is Okay for Adjuvant Chemotherapy for Early Lung … - Jun 3, 2006 But no older patient completed the full 16-dose Navelbine regimen and only 31.8% received the recommended eight doses of Platinol, which was significant ... MedPage Today Adjuvant Chemotherapy Helps Lung Cancer Patients - Jun 22, 2005 Advise interested patients of increased survival with adjuvant treatment with Navelbine (vinorelbine) plus Platinol (cisplatin) for patients with good ... MedPage Today Press Release: ADVENTRX Meets Primary Endpoint in ANX-530 … - Nov 16, 2007 Pharmacokinetic equivalence, the primary endpoint of the study, was observed between ANX-530 and Navelbine(R), the reference product, in patients with ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: ADVENTRX Announces Completion of Patient Enrollment … - Oct 10, 2007 Vinorelbine tartrate, marketed under the brand name Navelbine(R), is an anti-cancer agent that is approved to treat advanced non-small cell lung cancer as a ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Complete ANX-530 Safety Data to be Published in the … - Mar 10, 2008 Navelbine, a branded formulation of vinorelbine, is approved in the U.S. to ... Worldwide sales of Navelbine and generic formulations of vinorelbine in 2006 ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: ADVENTRX Cleared to Initiate Vinorelbine Emulsion … - Dec 26, 2006 The study is a multicenter, open-label, randomized crossover comparison of ANX-530 and the approved reference product Navelbine(R) (vinorelbine tartrate) in ... Pay-Per-View - PR Newswire - HighBeam Research Gene Profiling Predicts Resistance to Breast Cancer Drug - Feb 20, 2007 ..."We were motivated to use Navelbine because we found it has few side effects when used to treat metastatic breast cancer," said Harris, who conducted much ... DG News ADVENTRX Announces Positive FDA Pre-IND Meeting Outcome - Dec 7, 2005 ANX-530 has demonstrated the ability to markedly reduce injection-site irritation in pre-clinical testing, compared to Navelbine(R), GlaxoSmithKline's ... RedOrbit Mesothelioma & Asbestos Awareness Center Acknowledges - Jul 24, 2008 Common side affects associated with Navelbine, an anti-cancer chemotherapy drug, include low blood counts, muscle weakness, and vomiting. ... TransWorldNews - TransWorldNews (press release) Ontario makes Herceptin widely available - Jul 22, 2005 The government has promised $148-million to pay for Herceptin and two other drugs — Navelbine for lung cancer and Taxotere for prostate cancer. ... Globe and Mail Press Release: ADVENTRX Announces ANX-530 Safety Data From … - May 16, 2008 System Organ Class/Preferred Term ANX-530 Navelbine P value General Disorders and Administration Site Conditions 514 0.014 Infusion Site Phlebitis 1*7 ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Roche Requests Re-Examination of CHMP Opinion on … - Sep 5, 2006 Article: Study of Navelbine plus gemcitabine suggests ... Drug Week; December 13, 2002 ; 687 words ... ... infusion on day 1 of each cycle, ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: ADVENTRX Announces ANX-514 Clinical Development … - Sep 10, 2007 The FDA has indicated that this ... indicate bioequivalence of ANX-530 and Navelbine; the FDA's views on the appropriateness ... seeking marketing approval ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: ADVENTRX Announces Positive FDA Pre-IND Meeting … - Dec 7, 2005 PR Newswire; April 15, 2008 ; 700+ words ... ... analyses, relative to Navelbine, ANX-530 demonstrated a statistically significant reduction in injection ... Pay-Per-View - PR Newswire - HighBeam Research Longartsen oneens met zorgverzekeraars - Aug 15, 2005 Navelbine wordt vergeleken met Gemzar. Farmaciebedrijf Eli Lilly zegt: 'Gemzar is ... Mensen die Navelbine gebruiken moeten vaker worden opgenomen en dat is ... Zorgkrant RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in … - Dec 12, 2008 In the study, RAD001 in combination with Herceptin and Navelbine halted tumor growth in 62% of patients. "Data presented at this meeting affirm the ... Genetic Engineering News - Genetic Engineering News (press release) 肺癌化療一線用藥新çª?ç ´ï½žå?£æœ?藥「溫諾平ã€?å?¥ä¿?4月給付 - Mar 31, 2006 ...é?žå°?細胞肺癌一線用藥溫諾平(Navelbine)，為å?£æœ?è† å›Šï¼Œçª?ç ´ä»¥å¾€ç¬¬ä¸€ç·šé‡?劑化療法，更 æ??高許多便利與接å?—度。 é?žå°?細胞肺癌病患一線化療用藥ç?¾åœ¨æœ‰äº†æ–°é?¸æ“‡ï¼Œçª?ç ´ä»¥å¾€ ... NOWnews Bloomberg Printer-Friendly Page - Dec 15, 2008 ANX-530 (vinorelbine emulsion) is a reformulation of Navelbine(R) which, despite being a generic product for a number of years, still sells in excess of ... Bloomberg Surgery, radiation, chemo, recombinant antibody combat breast cancer;... - Mar 1, 2005 Vinorelbine (Navelbine) 25-30 mg/[m.sup.2] IV weekly Capecitabine (Xeloda) 1250 mg/[m.sup.2] PO twice daily d1-14 every 21 days 800-1200 mg/[m.sup.2] IV ... Free with registration - Managed Healthcare Executive - AccessMyLibrary.com Lung Cancer - Health News Story - WSOC Charlotte - Sep 21, 2007 ...paired combinations of chemotherapy drugs: carboplatin and paclitaxel, cisplatin and navelbine, cisplatin and docetaxel and cisplatin and gemcitabine. ... WSOCtv.com Taxotere and Herceptin Reduces Recurrence of Early-Stage Breast … - May 18, 2006 In this study, Herceptin was given after Taxotere or Navelbine, but BEFORE the FEC ... This is the first time Navelbine and Taxotere were compared for their ... Breastcancer.org Jung Chan Investment Inc acquires Ta Ho Electronics Inc (pending) - … - Jun 30, 2008 ...…s Navelbine (vinorelbine), BMS's Ta xol (paclitaxel) and Aventis's…lot of doctors will use Ta xotere/estramustine, but there will…research is required ... Pay-Per-View - deals - Alacra Store Adjuvant and Neoadjuvant Chemotherapy for Breast Cancer - Dec 8, 2005 Taxotere was superior with a significantly better outcome than Navelbine. A subgroup of 252 patients who were HER-2 + were randomized to chemo plus or minus ... Cancer Consultants Analysis by: GLG Expert Contributor - Jul 9, 2007 Any drug that can give further palliation will be welcomed but a head to head to head trial with Gemzar and Navelbine in this setting would be of interest. Gerson Lehrman Group Tratamiento vÃa oral para cáncer de mama y pulmón - May 24, 2006 Con la introducción en el mercado local de Navelbine Oral (vinorelbine), ... A partir del lanzamiento de Navelbine Oral, se genera la alternativa de que ... Asteriscos Chemotherapy Resistance Testing in Lung Cancer Patients Needs to Be … - Mar 17, 2007 ...and navelbine, cisplatin and docetaxel and cisplatin and gemcitabine. ... 24 percent to cisplatin-navelbine, 42 percent to cisplatin-gemcitabine and 27 ... emaxhealth.com Ny dyr lungekreftmedisin godkjent - Jun 6, 2008 I Norge bruker man en annen medisin enn den som Alimta er sammenlignet med; nemlig Navelbine. - Det er ikke gjort sammenlignende studier med Navelbine, ... Dagens Medisin Netherlands Corporate News - Kyowa Hakko interimwinsten blijven … - Oct 31, 2005 In new drug development in Japan, applications for additional indications in respect of Navelbine, an anticancer drug, and Activacin, a thrombolytic agent ... Netherlands Corporate News - Netherlands Corporate News (persbericht) 7online.com: Health News from WABC-TV, The News Leader in New York … - Feb 22, 2006 The New England Journal of Medicine reports on a study comparing the drugs Taxotere and Navelbine in early breast cancer. A study of women who received ... go.com Survival Benefit With Chemotherapy in Non–Small-Cell Lung Cancer - Aug 24, 2006 The results come from the Adjuvant Navelbine International Trialist Association (ANITA) study, published online August 16 in Lancet Oncology, ... Medscape Emergency Disaster Systems Attends "The 2nd Annual National … - Oct 11, 2007 Vinorelbine tartrate, marketed under the brand name Navelbine , is an ... Worldwide annual sales of Navelbine and generic vinorelbine in 2006 were ... $4.95 - M2 Presswire - ECNext StreetInsider.com Pre-Open Movers 12/26 - Dec 26, 2006 Navelbine is an anti-cancer agent approved for use in non-small cell lung cancer. Fuwei Films Co., Ltd. (Nasdaq: FFHL) 13% HIGHER; last week's IPO extends ... StreetInsider.com - StreetInsider.com (subscription) Commissioners in Carbon OK action over prescriptions ** Officials... - May 25, 2007 Navelbine is used for treating cancer, specifically some lung cancers. Retrovir is used for treating HIV infection. Ventolin is used to treat breathing ... Pay-Per-View - Morning Call - ProQuest Archiver Press Release: Research and Markets: See the Much Awaited Global … - Jun 10, 2005 GAIN ACCESS TO NEW GEOGRAPHICAL MARKETS Introduction Case study: Pierre Fabre GlaxoSmithKline and Navelbine Navelbine (vinorelbine) Licensing to ... Pay-Per-View - M2 Presswire - HighBeam Research Research & Markets: New Report Examines the Historical and … - Dec 28, 2006 Navelbine Lercan Fractal Therapy area analysis, 2005-11 Oncology Womens health ... Navelbine Busulfex Cardiovascular Lercanidipine + enalapril Fractal 113 ... Free with registration - Business Wire - AccessMyLibrary.com ADVENTRX Announces Restructuring and Cost Reduction Initiatives - Oct 20, 2008 Navelbine(R), a branded formulation of vinorelbine, is approved in the US to treat advanced non-small cell lung cancer as a single agent or in combination ... Genetic Engineering News - Genetic Engineering News (press release) American Pharmaceutical Partners Receives Approval for Vinorelbine … - Apr 19, 2005 Navelbine(R) is a registered trademark of GlaxoSmithKline PLC. CONTACT: Nicole Williams, Executive Vice President & CFO of American Pharmaceutical Partners, ... $4.95 - PR Newswire - ECNext Longkankerpatiënten vrezen verlies chemovergoeding - Sep 15, 2006 Die stellen op basis van het oordeel van het adviescollege CVZ dat Navelbine uitwisselbaar is met de chemotherapieën Gemzar, Taxol en Taxotere. ... NU.nl La planta prodigiosa contra el cáncer - Sep 7, 2008 Con la molécula extraÃda de la planta, se da la fabricación de Navelbine un medicamento que ha demostrado una eficacia frente a algunos cánceres de mama. ... IBLNEWS La planta sublime - Aug 20, 2008 Con la molécula extraÃda de la planta, se da la fabricación de Navelbine un medicamento que ha demostrado una eficacia frente a algunos cánceres de mama. ... El Universal - El Universal (México) Breast Cancer; Studies from the United States and Greece add new … - May 3, 2006 Study 2: Fluorouracil-epirubicin-navelbine (FEN) was deemed an effective first-line chemotherapy treatment for patients with advanced breast cancer (BC). ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Novartis' Afinitor may overcome Herceptin resistance; Ph I study. - Dec 22, 2008 In the study, Afinitor plus Herceptin and Navelbine halted tumor growth in 62% of patients. Copyright 2008 Marketletter Publications Ltd. $9.94 - Pharma Marketletter - Alacra Store Breast Cancer; Findings advance knowledge in breast cancer research - Apr 12, 2006 Study 1: Fluorouracil-epirubicin-navelbine (FEN) was deemed an effective first-line chemotherapy treatment for patients with advanced breast cancer (BC). ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Press Release: RAD001 Shows Potential to Reverse Resistance to … - Dec 12, 2008 In the study, RAD001 in combination with Herceptin and Navelbine halted tumor growth in 62% of patients. "Data presented at this meeting affirm the ... Pay-Per-View - PR Newswire - HighBeam Research vinorelbine Pierre Fabre, Novacea licensing termination. - Nov 13, 2006 Vinorelbine (NAVELBINE) is a semisynthetic vinca alkaloid marketed worldwide for the treatment of nonsmall cell lung cancer and in Canada and Europe for the ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones vinorelbine Pierre Fabre conducting phase II trial of oral formulation... - Sep 18, 2006 Vinorelbine iv (NAVELBINE) is marketed in many markets worldwide for the treatment of nonsmall cell lung cancer (NSCLC) and breast cancer. ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Press Release: ADVENTRX to Present Complete ANX-530 … - Feb 7, 2008 The primary endpoint in the study was met, with pharmacokinetic equivalence observed between ANX-530 and the reference drug Navelbine(R). ... Pay-Per-View - PR Newswire - HighBeam Research Research & Markets: New Report Examines the Historical and Forecast … - Dec 28, 2006 Navelbine Lercan Fractal Therapy area analysis, 2005-11 Oncology Womens health ... Navelbine Busulfex Cardiovascular Lercanidipine + enalapril Fractal 113 ... $4.95 - Business Wire - ECNext Operating income up 21% at Kyowa Hakko. - Feb 4, 2008 Navelbine drives pharmaceutical revenues Sales for the period rose 11% to 297.0 billion yen, with an expanded contribution from key drug products such as ... $9.94 - Pharma Marketletter - Alacra Store Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC – a... - Nov 23, 2006 Milleron B, Brambilla C, Blanchon F, Patte F, Quoix E, Taytard A, Naman H (1991) Pierre Fabre Oncology Navelbine; Update and New Trends. ... Nature.com La chimiothérapie orale : un vrai plus ! - Santé vie pratique - < … - Mar 20, 2007 Mais la liste va s'élargissant et comprend déjà des tumeurs très fréquentes comme, par exemple les cancers du sein (Navelbine, Capécitabine) et du poumon ... Témoignages.re Une nouvelle molécule trois en un - Jul 14, 2007 ...une nouvelle molécule Navelbine, qui a prouvé, selon les spécialistes, son efficacité dans ... Navelbine offre des avantages majeurs pour le patient ». ... El Watan Pierre Potier, disparition d'un grand scientifique - Feb 3, 2006 NAVELBINE® et TAXOTÈRE® sont deux médicaments anticancéreux français distribués dans le monde entier qui contribuent à sauver des milliers de vie chaque ... CNRS - CNRS (Communiqués de presse) Corriere.com - Corriere Canadese Online - Jul 23, 2005 Si tratta dell'Herceptin, del Navelbine e del Texotere. Smiterhman: decisione importante per i pazienti. Tre costosi farmaci per la lotta al cancro saranno ... Corriere Canadese Longkankerpatiënten vrezen verlies chemovergoeding - Sep 18, 2006 Die stellen op basis van het oordeel van het adviescollege CVZ dat Navelbine uitwisselbaar is met de chemotherapieën Gemzar, Taxol en Taxotere. ... Ziekenhuis.nl Hommage à la mémoire du grand chimiste et pharmacien Pierre Potier - May 12, 2006 Les laboratoires Pierre Fabre avaient acquis, de leur côté, les droits sur la Navelbine , dont le marché dépasse 150 millions d'euros. ... CNRS - CNRS (Communiqués de presse) Primer tratamiento totalmente por vÃa oral contra el cáncer - May 6, 2006 Con la introducción en el mercado local de Navelbine Oral (vinorelbine), ... A partir del lanzamiento de Navelbine Oral, se genera la alternativa de que ... Asteriscos 醫師:乳癌å?£æœ?性化療藥å?¥ä¿?給付多種é?¸æ“‡ - Oct 16, 2007 ...å¼µé‡‘å …èªªï¼Œé€™æ¬¡å?£æœ?å¼?乳癌化療用藥（溫諾平NAVELBINE）通é?Žè½‰ç§»æ€§ä¹³ç™Œçµ¦ä»˜å¾Œï¼Œå°?æ–¼ 符å?ˆçµ¦ä»˜æ¨™æº–的患者來說，æ¯?次療程å?¯çœ?下約新å?°å¹£äºŒè‡³ä¸‰è?¬å…ƒï¼Œè€Œå®Œæ•´çš„æ²»ç™‚é€šå¸¸ä»¥å… ... epochtimes.com Viestin aihe: Aromasiini - Nov 12, 2007 Navelbine-hoito kestää näillä näkymin helmikuuhun ja sitten kai siirrytään takaisin ... Nyt olen ollut navelbine päivästä asti kuumeessa, mutta tutkittuani ... Verkkoklinikka Bei frühem Lungen-Ca nutzt adjuvante Chemotherapie - Aug 1, 2005 Das hat die ANITA-Studie (Adjuvant Navelbine International Trialist Association) bestätigt, deren 70-Monats-Daten in Orlando vorgestellt worden sind. ... Ärzte Zeitung Mejoran sobrevida de pacientes con cáncer - Nov 1, 2006 Los excelentes resultados obtenidos por Navelbine®, medicamento del laboratorio francés Pierre Fabre, formulado en base a la droga vinorelbine, ... Asteriscos Tuesday's Small-Cap Winners & Losers - Dec 26, 2006 ...proposed cancer drug ANX-530, deeming it to be bioequivalent to Navelbine, an existing cancer treatment approved for use in nonsmall-cell lung cancer. ... TheStreet.com - TheStreet.com (subscription) Ovarian Cancer Medications - Ovarian Cancer Health Information - NY … - Dec 24, 2008 Other drugs used for recurrent ovarian cancer include doxorubicin (Adriamycin, Doxil), etoposide (Vepesid), and vinorelbine (Navelbine). ... New York Times Genes May Boost Lung Cancer Chemo - Apr 11, 2007 White's team also tested six Taxol-sensitive genes with two other chemotherapy drugs, Navelbine and Gemzar. The Taxol-sensitive genes weren't very sensitive ... WebMD Press Release: Lorus announces results of Virulizin(R) Phase III... - Oct 18, 2005 Article: Phase II Study of Navelbine Plus Gemcitabine ... PR Newswire; November 14, 2002 ; 700+ words ... ... paclitaxel 200 mg/m2 IV infusion on day 1 of ... Pay-Per-View - PR Newswire - HighBeam Research Article: US doctors scrutinize drug ads Group to consider backing a... - Jun 23, 2005 New drugs included: * Navelbine (vinorelabine tartrate), to treat ambulatory ... PR Newswire. Article: Merck and Company Inc. receives Food and Drug ... ... Pay-Per-View - International Herald Tribune - HighBeam Research 3 provinces add funding for costly breast cancer drug - Jul 25, 2005 Ontario will also pay for two other intravenous drugs, Navelbine (Vinorelbine) for lung cancer, and Taxotere (Docetaxel) for prostate cancer. ... CBC.ca Herbal hope in breast cancer battle - Nov 2, 2005 ...cancer tumours to other chemotherapy drugs, such as Taxol, Taxotere and Navelbine. It also enhances anti-oestrogen drugs such as tamoxifen and Faslodex. ... Scotsman Short-term T-bill rates up - Dec 27, 2006 The San Diego drug development company said it would conduct clinical trials to establish that its drug, ANX-530, works the same as Navelbine, ... San Diego Union - Tribune - San Diego Union Tribune Evening primrose oil could help beat breast cancer - Nov 3, 2005 ...at Northwestern University has shown that GLA sensitises breast cancer tumours to other chemotherapy drugs, such as Taxol, Taxotere and Navelbine. ... Daily Mail New treatment option studied for bladder cancer - Oct 31, 2007 ...and Asia will determine if those patients can benefit from vinflunine, which is in the same vinca alkaloid family as Navelbine®, used for lung cancer. ... Hindu CEL-SCI Announces Expansion of Exclusive Licensing Agreement for - Nov 3, 2008 ...an international Phase III cancer trial when it successfully executed its part in the Phase III clinical trial that led to the approval of Navelbine(R). ... Bloomberg Breast Cancer,Metastatic or Recurrent - Medications - Aug 31, 2007 Other medicines that may be used to treat advanced breast cancer include Taxol, Navelbine, Taxotere, gemcitabine, lapatinib (Tykerb), and capectabine. ... WebMD Can adjuvant chemotherapy improve survival in patients with early... - Aug 17, 2005 The Adjuvant Navelbine International Trialist Association (ANITA) trial randomized patients with resected stage IB–IIIA NSCLC to adjuvant high-dose ... Nature.com Breast Cancer Treatments' Links to Heart Disease Calculated - Aug 15, 2006 Sixty-three percent of the women had concomitant Navelbine (vinorelbine) and 84% received concomitant taxanes. In the second study, Dr. Harris and ... MedPage Today Espoir pour les diabétiques - Apr 18, 2005 ...membre de l'Académie des sciences et, par ailleurs, à l'origine de la mise au point de deux médicaments anticancéreux, la Navelbine et le Taxotère. ... L'Express å?‹è?¯ç”ŸæŠ€æº«è«¾å¹³å?£æœ?è† å›Šç´?å…¥å?¥ä¿?給付挹注下å?Šå¹´ç‡Ÿæ”¶ - Jul 6, 2006 ...å?‹è?¯ç”ŸæŠ€(4120)旗下藥å“?『溫諾平å?£æœ?è† å›Šã€?(Navelbine Oral)ç?²å¾—å?¥ä¿?å±€æ ¸å?¯ï¼Œæˆ?為第 一個ç´?å…¥å?¥ä¿?給付治療é?žå°?細胞肺癌的å?£æœ?第一線化療用藥，é ?ä¼°å°‡å?¯é€²ä¸€æ¥å¸¶å‹•ä¸‹å?Šå¹´ ... NOWnews Décédés, actualité Société : Le Point - Jan 17, 2007 Il met au point un test biologique simple dit « à la tubuline », ce qui lui permet de découvrir la navelbine et le taxotère, deux molécules révolutionnaires ... Le Point |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |